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Introduction
Exome sequencing is the process by which exonic portions
of the genome are selectively enriched from genomic DNA
samples and sequenced using next generation methodolo-
gies. It has been used extensively since 2009 to identify the
pathogenic variants underlying Mendelian disorders.
Objectives
The Inflammatory Disease Section in NHGRI has con-
ducted exome sequencing on 162 subjects from families
with a variety of unexplained autoinflammatory, autoim-
mune, and allergic diseases, to determine the disease etiol-
ogies, inform treatments plans, or provide a molecular
diagnosis to patients.
Methods
Samples were prepared at the NIH Intramural Sequencing
Center using one of four different exome capture kits, and
libraries were sequenced on the Illumina HiSeq 2000 plat-
form using 2x100 bp paired-end reads, to an average
depth of coverage in the target intervals of 68X across all
samples, and with an average of 89% of target bases pro-
ducing high-confidence calls. The raw data are analyzed
according to the following pipeline: per-sample alignment
of reads to the human reference genome with Novoalign
and removal of PCR duplicate reads with Picard, followed
by multi-sample re-alignment around small insertions and
deletions, re-calibration of per-base quality scores, variant
calling, and re-calibration of variant quality scores using
the Genome Analysis Tool Kit (GATK), and finally variant
annotation with Annovar. These steps are performed
using the high-performance Biowulf Linux compute clus-
ter at NIH. Generally, annotated variants are filtered to
include only those that are nonsynonymous or in splice
sites, within linkage intervals (if available), absent from
dbSNP v132, have less than 0.1% frequency in 1094 gen-
omes from the 1000 Genomes Project, 6503 exomes from
the Exome Sequencing Project, and 938 exomes from
the NHGRI ClinSeq project, and co-segregate with the
phenotype among all sequenced family members. Putative
candidates are then individually examined in the Inte-
grated Genome Viewer (IGV) to eliminate probable false-
positives arising from low coverage or mis-aligned reads,
and variants passing this check are validated by Sanger
sequencing and tested for co-segregation in all available
family members.
Results
We have compared two popular alignment programs,
BWA and Novoalign, as well as two popular variant calling
tools, SamTools and GATK, and determined that the
combination of Novoalign and GATK usually provides the
best compromise between specificity and sensitivity for
the purposes of Mendelian disease gene identification.
Our lab has identified or is currently pursuing the genetic
causes of several disorders using the above methodology.
Conclusion
This approach has been most successful for recessive
families with consanguinity or multiple affected indivi-
duals, dominant families large enough to produce at least
suggestive LOD scores in linkage scans, or families with
transmitted de novo mutations. For small families and sin-
gle cases the major challenge is that filtered variant lists
contain tens or hundreds of candidates, in which case
additional family members or new families with the same
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